Item | Information |
---|---|
CAS RN | 7447-41-8 |
Chemical Name | Lithium chloride |
Substance ID | m-nite-7447-41-8_v2 |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | To Guidance List |
UN GHS document (External link) | To UN GHS document |
FAQ(GHS classification results by the Japanese Government) | To FAQ |
List of Information Sources (Excel file) | List of Information Sources |
List of Definitions/Abbreviations | Definitions/Abbreviations |
Sample Label by MHLW (External link) | MHLW Website (in Japanese Only) |
Sample SDS by MHLW (External link) | MHLW Website (in Japanese Only) |
OECD/eChemPortal (External link) | To OECD/eChemPortal (External link) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Explosives | Not classified (Not applicable) |
- |
- | - | There are no chemical groups associated with explosive properties present in the molecule. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
2 | Flammable gases | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
3 | Aerosols | Not classified (Not applicable) |
- |
- | - | Not aerosol products. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
4 | Oxidizing gases | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
5 | Gases under pressure | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
6 | Flammable liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
7 | Flammable solids | Not classified |
- |
- | - | Not combustible (ICSC (1997)) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
8 | Self-reactive substances and mixtures | Not classified (Not applicable) |
- |
- | - | There are no chemical groups present in the molecule associated with explosive or self-reactive properties. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
9 | Pyrophoric liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
10 | Pyrophoric solids | Not classified |
- |
- | - | Not combustible (ICSC (1997)) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
11 | Self-heating substances and mixtures | Not classified |
- |
- | - | Not combustible (ICSC (1997)) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
12 | Substances and mixtures which, in contact with water, emit flammable gases | Not classified |
- |
- | - | Although it contains a metal (Li), its water solubility is 83.2 g/100 g water (20 degC) (Ullmanns) (6th, 2003)) and it is considered that the substance doesn't react strongly with water. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
13 | Oxidizing liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
14 | Oxidizing solids | Classification not possible |
- |
- | - | This substance is an inorganic compound containing halogen atom (Cl), but classification is not possible because no data is available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
15 | Organic peroxides | Not classified (Not applicable) |
- |
- | - | Inorganic compound | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
16 | Corrosive to metals | Classification not possible |
- |
- | - | Test methods applicable to solid substances are not available. In addition, it is reported that the aqueous solution corrodes metals (ICSC (1997)). | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
17 | Desensitized explosives | - |
- |
- | - | - | - | - |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Category 4 |
Warning |
H302 | P301+P312 P264 P270 P330 P501 |
Based on the rat LD50 values of 526 - 840 mg/kg bw (IUCLID (2000)) and 757 mg/kg bw (HSDB (2007)), the substance was classified into Category 4. [For health hazards, refer also to other lithium compounds.] |
FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Dermal) | Classification not possible |
- |
- | - | No data available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Inhalation: Gases) | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Inhalation: Vapours) | Classification not possible |
- |
- | - | No data available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
1 | Acute toxicity (Inhalation: Dusts and mists) | Classification not possible |
- |
- | - | No data available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
2 | Skin corrosion/irritation | Category 2 |
Warning |
H315 | P302+P352 P332+P313 P362+P364 P264 P280 P321 |
The substance was classified as Category 2 based on the documented case of "irritating" resulted from rabbit test (Directive 84/449/EEC, B.4, GLP-compliant) in which one of 3 animals showed irreversible crust formation in 14 days (IUCLID (2000)). | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
3 | Serious eye damage/eye irritation | Category 2A |
Warning |
H319 | P305+P351+P338 P337+P313 P264 P280 |
The substance was classified as Category 2A based on the documented case of "moderately irritating" resulted from rabbit test (GLP-compliant) in which the irritation was most severe 1 hour after the instillation, and it recovered by day 7 in washed eyes and by day 16 in the unwashed. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | No data available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
4 | Skin sensitization | Classification not possible |
- |
- | - | No data available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
5 | Germ cell mutagenicity | Not classified |
- |
- | - | The positive data in the chromosome aberration test using bone marrow obtained from mice by oral administration and the negative data in the sister chromatid exchange test were reported (IUCLID (2000)). However, these data contained many improperness, and also details of the test method were not provided there. Therefore, the clear conclusion was not possible based on these data. Thus, the positive results in the chromosome aberration test/micronucleus test in this substance or other lithium compounds (KemI-Riskline NR 2002: 16) were sometimes found, but, these data had problematic issues with the test methods and others. On the other hand, because the negative data in the chromosome aberration test were also reported (KemI-Riskline NR 2002: 16), the induction of chromosome aberration was unclear. Therefore, based on the overall evaluation by weight-of-evidence, the substance was concluded as "Not classified". As relevant information, as for in vitro tests, the bacterial reverse mutation test with negative results (NTP DB (Access on Apr. 2010), KemI-Riskline NR 2002: 16) and the chromosomal aberration test using human peripheral blood culture cells with positive results (IUCLID (2000), KemI-Riskline NR 2002: 16) were reported. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
6 | Carcinogenicity | Classification not possible |
- |
- | - | No data available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
7 | Reproductive toxicity | Category 1A, |
Danger |
H360 H362 |
P308+P313 P201 P202 P260 P263 P264 P270 P280 P405 P501 |
In preparation. Check the Japanese version. | FY2022 | GHS Classification Guidance for the Japanese Government (FY2019 revised edition (Ver. 2.1)) |
8 | Specific target organ toxicity - Single exposure | Category 2 (nervous system) |
Warning |
H371 | P308+P311 P260 P264 P270 P405 P501 |
In the acute oral toxicity study in mice, it was reported that the LD50 value was 1,165 mg/kg, and toxic signs included paralytic gait of hindlimbs, stupor with subsequent death, muscle weakness or muscle spasms (IUCLID (2000)). It was also reported in the other studies (dose levels: 1,500 – 3,000 mg/kg) that clinical signs observed were as follows: lethargy, slow respiration, slow response to external stimuli, convulsion prior to death (IUCLID (2000)). Since these clinical signs in mice were seen in dose levels within Category 2 of the guidance values, the classification was determined as Category 2 (nervous system). As the additional information, the therapeutic use of lithium carbonate as an active ingredient may produce unusual toxic response depending on the blood lithium concentrations (KemI-Riskline NR 2002:16, Handbook of Japanese pharmaceutical drugs (2010)). According to a medical package insert, it is recommended to monitor the blood lithium concentration as a precaution of usage (Handbook of Japanese pharmaceutical drugs (2010)). Furthermore, it was also reported that in patients receiving lithium therapy, severe neurotoxicity might occur which included impaired consciousness, delirium, ataxia, generalized fasciculation and extrapyramidal symptoms when the plasma lithium level would exceed 2.5 mM, and that the toxicity might occur for a few days from a few hours (KemI-Riskline NR 2002:16). |
FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
9 | Specific target organ toxicity - Repeated exposure | Category 2 (nervous system, kidney) |
Warning |
H373 | P260 P314 P501 |
In repeated dose study in rats for up to 2 years via drinking water, the rats given the substance at a dose equivalent to 106 mg/kg/day revealed drowsiness and lethargy and subsequent muscle tremor and weakness after 3-5 days of commencement of treatment, and they died within 2 - 3 weeks (IUCLID (2000)). In repeated oral dose toxicity study with dogs for up to 150 days, deaths occurred at 100 mg/kg/day, and the symptoms prior to death included tremors, lethargy, salivation, muscular weakness, extreme weakness, etc. (IUCLID (2000)). Additionally, in the other repeated oral dose toxicity study with dogs for up to 57 weeks (dose levels: 20, 50 and 100 mg/kg/day), renal damage with histopathological lesions in the distal convoluted tubules and collecting ducts were observed (IUCLID (2000)). All these findings were observed in the dose-range equivalent to Category 2 defined as the guidance values, and thus the classification was decided as Category 2 (nervous system, kidney). In humans, it was reported that the signs of lithium intoxication such as drowsiness, tremors, neuromuscular irritability developed by usage of the substance as a substitution for sodium chloride (IUCLID (2000)), and that some of the patients who were fed and maintained with low sodium diet developed chronic renal insufficiency (KemI-Riskline NR 16 (2003)). As additional information on the other lithium compounds, oral ingestion of a psychotropic drug which includes lithium carbonate as an active ingredient induced side effects such as tremor, lethargy, and confusion were described (KemI-Riskline NR 2002:16, Handbook of Japanese pharmaceutical drugs (2010)). The occurrence of clinical signs depended on the blood lithium concentration, and those included neurological toxicity progressing from hand tremor, muscle weakness toward coma (KemI-Riskline NR 2002:16). Moreover, in a follow up study for the patients treated with lithium preparation, treatment-related side effects included tremor, subjective memory loss and loss of creativity (IUCLID (2000)). While, as the side effects other than nervous system, cases with polyuria, polydipsia or nephrogenic diabetes insipidus were reported (KemI-Riskline NR 2002:16, Handbook of Japanese pharmaceutical drugs (2010)), and it was also described that chronic renal failure might occur (KemI-Riskline NR 2002:16). |
FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
10 | Aspiration hazard | Classification not possible |
- |
- | - | No data available. | FY2010 | GHS Classification Guidance by the Japanese Government (July, 2010) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment Short term (Acute) | Not classified |
- |
- | - | In preparation. Check the Japanese version. | FY2022 | GHS Classification Guidance for the Japanese Government (FY2019 revised edition (Ver. 2.1)) |
11 | Hazardous to the aquatic environment Long term (Chronic) | Not classified |
- |
- | - | In preparation. Check the Japanese version. | FY2022 | GHS Classification Guidance for the Japanese Government (FY2019 revised edition (Ver. 2.1)) |
12 | Hazardous to the ozone layer | Classification not possible |
- |
- | - | In preparation. Check the Japanese version. | FY2022 | GHS Classification Guidance for the Japanese Government (FY2019 revised edition (Ver. 2.1)) |
|